Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Anatomy Item Literature (1949) Expression Attributions Wiki
XB-ANAT-3904

Papers associated with plasma membrane (and slc16a3)

Limit to papers also referencing gene:
Show all plasma membrane papers
???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

Identification of a selective inhibitor of human monocarboxylate transporter 4., Futagi Y., Biochem Biophys Res Commun. January 1, 2018; 495 (1): 427-432.

The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters., Nancolas B., Biochem J. April 1, 2016; 473 (7): 929-36.

Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity., Nancolas B., Biochem J. February 15, 2015; 466 (1): 177-88.                    

The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein., Ovens MJ., Biochem J. October 15, 2010; 431 (2): 217-25.              

AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10., Ovens MJ., Biochem J. January 15, 2010; 425 (3): 523-30.              

The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity., Manoharan C., Mol Membr Biol. January 1, 2006; 23 (6): 486-98.                

???pagination.result.page??? 1